Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission [Phase 4]
A Phase 4 pilot study evaluated whether stable rheumatoid arthritis patients in clinical remission could discontinue adalimumab therapy.
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA) [Phase 3]
This Phase 3 trial compared different methotrexate dosing regimens when taken with adalimumab in patients with early rheumatoid arthritis. T…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine [Phase 4]
This document reports a Phase 4 clinical trial evaluating the effect of tocilizumab on the cellular immune response to influenza vaccination…
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: SB-681323 In Subjects With Rheumatoid Arthritis [Phase 2]
A Phase 2 study of SB-681323 in rheumatoid arthritis has completed; the document does not include efficacy or safety results.
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Improving Motivation for Physical Activity in Arthritis Clinical Trial [NA]
A Northwestern University clinical trial aimed at improving motivation for physical activity in people with knee osteoarthritis and rheumato…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis [Phase 3]
This clinical trial update describes a Phase 3, multi-center study evaluating three doses of meloxicam versus placebo in patients with rheum…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study
An observational trial update assessing the safety and efficacy of Mobic Inj. (meloxicam) in patients with osteoarthritis or rheumatoid arth…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study [Phase 3]
This document reports the completion and results posting for a Phase 3 follow-up trial in rheumatoid arthritis patients with moderate to low…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: A 6-Months Infliximab Or Placebo Study In UA At High Risk Of RA:Clinical,Radiological And Synovial Benefit [NA]
A completed 6-month clinical trial comparing infliximab to placebo in patients with undifferentiated arthritis at high risk of rheumatoid ar…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Study of the Response and Cardiorespiratory Endurance in Early RA Patients Treated With Tocilizumab or Methotrexate [NA]
This completed study assesses response and cardiorespiratory endurance in early rheumatoid arthritis patients treated with tocilizumab versu…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
Pfizer-sponsored trial investigating characteristics of patients with moderately active rheumatoid arthritis has completed and posted result…
-
FDA approval · 2013-10-28FDA Approved: DICLOFENAC SODIUM — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal's Original Application for Diclofenac Sodium Tablets, a generic NSAID indicated for relief of pain and inflammation in s…
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial evaluating subcutaneous tocilizumab with traditional DMARDs in moderate-to-severe rheumatoid arthritis completed. Results were…
-
FDA approval · 2013-10-21FDA Approved: ACTEMRA — Original Application (Genentech, Inc.)
FDA approved Actemra (tocilizumab) under an Original Biologics License Application from Genentech. The approval was for the treatment of rhe…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate [Phase 2]
Phase 2 trial results evaluating rituximab’s effects on immune responses in adults with active rheumatoid arthritis receiving background met…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis [Phase 1]
This report covers a first-in-man Phase 1 trial of the investigational compound NNC0142-0002 in patients with rheumatoid arthritis. The stud…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis [Phase 3]
This document reports a long-term extension study of tocilizumab in rheumatoid arthritis, with the Phase 3 trial completed and results poste…
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy [Phase 3]
Phase 3 study evaluating intravenous golimumab in patients with active rheumatoid arthritis despite methotrexate therapy; results from the t…
-
FDA approval · 2013-10-11FDA Approved: OTREXUP — Original Application (Antares Pharma, Inc.)
FDA approved OTREXUP, a subcutaneous methotrexate injection from Antares Pharma, under an original NDA for autoimmune conditions including r…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis [Phase 1]
Phase 1 trial update shows safety and tolerability data for REGN88 (SAR153191) in subjects with rheumatoid arthritis; study completed.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis [Phase 1]
A phase 1 safety study of a single dose REGN88 (SAR153191) in patients with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects [Phase 1]
Phase 1 study assessing safety and tolerability of REGN88 (SAR153191) given in multiple doses to rheumatoid arthritis patients. The study st…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece
A 3-year follow-up study of patients with moderate-to-severe rheumatoid arthritis in Greece treated with Humira (adalimumab). Results were p…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis [Phase 1]
This Phase 1 trial used Dynamic Contrast-Enhanced MRI to measure the response to etanercept in rheumatoid arthritis. The results were posted…
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis [Phase 2]
This Phase 2 study evaluated the efficacy and safety of BG00012 (dimethyl fumarate) in combination with methotrexate for active rheumatoid a…